Benefits of a point of care test for sexual health testing

publication_iconOur recently published studies have highlighted the economic and clinical benefits of incorporating a point-of-care nucleic acid amplification test for chlamydia and gonorrhoeae into sexual health clinics. In this article, some of the papers’ authors highlight the advantages over traditional immunoassay techniques for point-of-care detection.

The Clinical Services Journal. May 2014, p59-61.

Read Publication

Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics

This study aimed to explore the current patient pathways for the diagnosis and treatment of chlamydia and gonorrhoea in England. We conducted workshops in four sexual health clinics, and asked them detail the steps and resources used in screening, diagnosis and treatment, and what would change if they had a point of care test (POCT) for chlamydia and gonorrhoea diagnosis. Using a POCT could lead to reduced clinical time and costs, and may lead to more appropriate and quicker care for patients.

Read Journal ArticleAdams EJ, Ehrlich A, Turner KME, et al. Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK. BMJ Open 2014;4:e005322. doi:10.1136/bmjopen-2014-005322

Read Publication

The cost-effectiveness of point of care tests for chlamydia and gonorrhoeae in sexual health clinics

Replacing standard laboratory tests for chlamydia and gonorrhoea with a rapid point of care test could be cost-effective if implemented in genitourinary medicine clinics in England. It could save the National Health Service an estimated £10 million annually, and patients would benefit from fewer unnecessary treatments and reduced complications from infection, and it could prevent the number of transmissions.

publication_iconTurner KME, Round J, Horner PJ, et. al. What are the clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary medicine clinics in England? Sex Transm Infect. Published online 22 Nov 2013: doi:10.1136/sextrans-2013-051147

Read Publication